You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDASI

Showing 76 - 100 of 327
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire

Recruiting
  • Locally Advanced Neuroendocrine Neoplasm
  • Metastatic Neuroendocrine Neoplasm
  • Placebo Administration
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)

Suspended
  • Gliosarcoma
  • MGMT-Unmethylated Glioblastoma
  • Ipilimumab
  • +6 more
  • Birmingham, Alabama
  • +285 more
Aug 24, 2022

Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)

Recruiting
  • Oropharynx Cancer
  • therapeutic conventional surgery
  • +5 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 4, 2022

Recurrent Head and Neck Carcinoma Trial in Houston (Intensity-Modulated Radiation Therapy, Proton Radiation, Stereotactic Body

Recruiting
  • Recurrent Head and Neck Carcinoma
  • Intensity-Modulated Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 16, 2022

Gynecologic Cancer, Chemo Effect, Mobile Application Trial (A mobile application intervention developed for gynecological cancer

Not yet recruiting
  • Gynecologic Cancer
  • +4 more
  • A mobile application intervention developed for gynecological cancer patients receiving chemotherapy
  • (no location specified)
Sep 26, 2022

HER2-positive Metastatic Breast Cancer, CNS Metastases Trial in Chicago, Boston (ATEZOLIZUMAB, PERTUZUMAB, TRASTUZUMAB)

Active, not recruiting
  • HER2-positive Metastatic Breast Cancer
  • Central Nervous System Metastases
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

High-grade Glioma Trial in Copenhagen (Family and Network Consultations)

Active, not recruiting
  • High-grade Glioma
  • Family and Network Consultations
  • Copenhagen, Denmark
    University hospital of Copenhagen, Rigshospitalet
Oct 25, 2022

Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Procedure: LITT
  • Hypo-Fractionated Radiation Therapy
  • Baltimore, Maryland
  • +3 more
Oct 10, 2022

Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

Recruiting
  • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Stem Cell Transplantation, Hematologic Malignancy Trial in Washington, Chicago, Hackensack (Expressive Helping, Factual Writing)

Active, not recruiting
  • Stem Cell Transplantation
  • Hematologic Malignancy
  • Expressive Helping
  • Factual Writing
  • Washington, District of Columbia
  • +2 more
Jun 9, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
May 1, 2023

Malignant Tumors of Lip Oral Cavity and Pharynx, Oropharyngeal Cancer Trial in Houston (procedure, behavioral, radiation)

Recruiting
  • Malignant Neoplasms of Lip Oral Cavity and Pharynx
  • Oropharyngeal Cancer
  • Modified Barium Swallow (MBS)
  • +6 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 24, 2019

Brain Connectivity After Tumor Resection

Recruiting
  • Brain Tumor
  • MRI
  • neuropsychological tests and qualitative assessment
  • Omaha, Nebraska
    UNMC/Nebraska Medicine
Sep 30, 2022

Carcinoma, Squamous Cell of Head and Neck, Oropharynx Squamous Cell Carcinoma Trial in Atlanta, Portland, Pittsburgh (Nivolumab

Active, not recruiting
  • Carcinoma, Squamous Cell of Head and Neck
  • Oropharynx Squamous Cell Carcinoma
  • Nivolumab Injection
  • Radiotherapy (RT)
  • Atlanta, Georgia
  • +2 more
Mar 24, 2022

IDH-mutant and IDH-wildtype Glioma Patients After

Recruiting
  • Glioma
  • RS-fMRI
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 8, 2022

Gliosarcoma, CNS Sarcoma Trial run by the NCI (Sunitinib, wGT3x-BT)

Terminated
Has Results
  • Gliosarcoma
  • Central Nervous System Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 24, 2022

Pancreatic Carcinoma Trial in Houston (Best Practice, Quadratus Lumborum Block, Quality-of-Life Assessment)

Active, not recruiting
  • Pancreatic Carcinoma
  • Best Practice
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • ATIR101
  • +3 more
  • Duarte, California
  • +41 more
Apr 28, 2022

Breast Cancer Trial in Shanghai (The RJBC-APP, Routine post-surgical follow-up)

Not yet recruiting
  • Breast Cancer
  • The RJBC-APP
  • Routine post-surgical follow-up
  • Shanghai, Please Select, China
    Xiaosong Chen
Jun 26, 2023

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Obinutuzumab, Venetoclax, Fludarabine)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Aurora, Colorado
  • +55 more
Jan 30, 2023

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 23, 2022

Brain Metastases Trial in Milwaukee (Stereotactic Radiosurgery)

Recruiting
  • Brain Metastases
  • Stereotactic Radiosurgery
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Mar 2, 2022

Leukemia, MDS Trial in Gainesville (Diet)

Recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • Diet
  • Gainesville, Florida
    UF Health Cancer Center
Aug 9, 2022

NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic

Not yet recruiting
  • NSCLC
  • +5 more
  • single fraction stereotactic radiosurgery (SSRS)
  • fractionated stereotactic radiosurgery (FSRS)
  • (no location specified)
Jan 18, 2023

Glioblastoma Trial in Ann Arbor (Dose-Intensified Radiotherapy, Temozolomide, Adjuvant temozolomide)

Recruiting
  • Glioblastoma
  • Dose-Intensified Radiotherapy
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021